ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000196.1|Anthraquinone_1 # 954 # 2108 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.340	BGC0000196.1|Anthraquinone_1 	954	2108	-	Loose	450	30.0314	aadA23	27.41	3002620	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGAATAATAAAAATAAACCCAATAGAATTTCGCCAGAACTTCTTGCTACTTGTGGTTATTTTATGCCAAGAATATTCTTCTTAAATTCTCAATATGCTCCCCAAGTTCATTGGGGAGATGTTGTTGCGGCATTGAGTCATTTTCCAGCGGGAAACTTAGACTTATCCTCTGAAGAGTTTTGGTATGAATGGATGATTAATTGGTCAAAAGTGGGTGATAGCTATATTAATATCGCTAACTCGGCTAAGAGTGAAGTTAGTCATGTTCGTGCTTTGAGGAGTGCCGCTGCCTGTTATCATTGGGCAGAATTTATGTATTTTAGTGATAGGAGTAGAAAGATACAGCTCAGAGAGTATATTCGTTCATGTTTTTTATCTAGTATAAAATATAGTGATTTGCTGGTTGACCACCAATATATTGTCGTCGATAAATTTCATATGCCGTTCTTCCTTATATTCCCTAAAGGGTATAAAGAAGAAGAGAATCATCCTTTGCCTTGTGTTATTTTATCCAATGGATTGGATTCAATGACTGAAATTGAAATATTATCTTTGGCCGAGTTTTTCTTAGGGAAAAATATGGCGGTAGCTATATTTGATGGACCAGGGCAGGGAATAAATCTTGGGAAATCACCAATAGCTATTGATATGGAATTATATGTTAGCTCTATAGTTAAATTATTAGAAGATGATGCCCGAATTAATAGTAATCTTCTTTGTTTCTTAGGAATTAGTTTTGGTGGTTATTTTGCTCTACGCGTTGCGCAAAGAATTGGCGATAAATTTTGTTGTATCGTCAATTTATCCGGTGGGCCTGAAATAGCAGAGTTTGATAAGTTGCCAAGAAGGCTTAAAGAAGATTTCCAGTTTGCATTTATGCAAGATAATAGTCATATGCAGTCTATTTTTGACGAAATTAAATTGGACATCTCTTTACCTTGTAAAACCAAGGTTTTTACTGTTCATGGTGAATTAGATGATATATTTCAGATCGATAAAGTGAAAAAATTAGATCAACTATGGGGTGATAATCACCAGTTATTATGTTATGAATCAGAGGCTCATGTTTGCTTAAATAAAATAAACGAATATATGATACAAGTTTCAGATTGGGTTAGTGAACAATTTTGGCTAAATGGCTATAAAAAAGGTTAA	MNNKNKPNRISPELLATCGYFMPRIFFLNSQYAPQVHWGDVVAALSHFPAGNLDLSSEEFWYEWMINWSKVGDSYINIANSAKSEVSHVRALRSAAACYHWAEFMYFSDRSRKIQLREYIRSCFLSSIKYSDLLVDHQYIVVDKFHMPFFLIFPKGYKEEENHPLPCVILSNGLDSMTEIEILSLAEFFLGKNMAVAIFDGPGQGINLGKSPIAIDMELYVSSIVKLLEDDARINSNLLCFLGISFGGYFALRVAQRIGDKFCCIVNLSGGPEIAEFDKLPRRLKEDFQFAFMQDNSHMQSIFDEIKLDISLPCKTKVFTVHGELDDIFQIDKVKKLDQLWGDNHQLLCYESEAHVCLNKINEYMIQVSDWVSEQFWLNGYKKG	MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	148.26	gnl|BL_ORD_ID|59|hsp_num:0	69			30	381	spectinomycin; streptomycin
BGC0000196.1|Anthraquinone_2 # 2128 # 3570 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.328	BGC0000196.1|Anthraquinone_2 	2128	3570	-	Loose	700	29.6462	ADC-201	27.63	3006370	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGAATTATGTAGAATCACATTCAATTATTTGTAATGCTCAGATAGAAGATGTATATGAAATTATTATTAATTCTGATAAATGGCCAGGAATGTTTGAACCTTGCCAGGAAGTAAAAACTCTCTTTAGGGATAAAGAAGGTGAAAAAATAGAAATTAAAGCCTTAATTAACGGTATATTAATGCAGTGGGAATCAAATCGTAAATTTTATCCAGAAACATTCAGTATAAAATCAAAACTGAATCCCCCAATGACATTAGTTAAAGAAATGGAAACGTCATGGCGCGTAATTAAAATCAATTCTCAGCAATGTGTACTGTTGTTGGAGCATTTATATGATCTTGAGTCTGAAGTAGCCGGGTTAATTGATGGTGTTGAAACAATAGAGCAGGCGCACCAATTTATTAGTAAAGCTATTGATACCAATTCAGTTAAAGAGCTCAATAATATAAAAAATATCGTCGAATCAACGGAGGGATCGGAAAAAGTATTAACAGGAACGATTACTCATTCAGTCGTATGTGAGGTGCCGGCACAGCAGGTTTATACTTTAGTTAAAGATGTCTCTTGTTGGACAGGTATTTTTTCATTCTGTGATGGTGCAGAAGTTTTAAAGAGATCAGGTAATGAAGAATTAGTTGAAATCAAAGCAAAACAAAATAATAAAGCAGTAAGTTGGCAAACGCAGCGATATTATTTTGATACTATTTACCGGGTTGATTATGTTATGCCTACACCGATGCCATTATTAAAAACAATGAATGGCAGATGGCAAATTATTCCTATTAATGATCAACGCTGTATTCTAACGGTACAAAGGAACTGGGGTTTATTAGAAGATGTCAGTGGTATCGTTGATGGTATTGATAATCATGACCAGGCTAATTCCTTTATTATCTCATTTATCAATGATAATACTCGAATGGAGATGGATAGTATAAAGAGTCAGGTAGAAAGTCATAAAAAATCAAATTTATTAACTTTCTCAGCGGGATATTATATTCCTCATCAGGTTGATGATGTTTATAAGATCTTTTTAAATATCGATGACTGGAGCAAGATATTACCGCATTGTGATTCAGTAAAAGTCATTTATAATGATGATAAACATCAAGAATTTAATATGGAAGTATCAACACCAAATGGAAATGAGACTTTCCGTAGTATACGATTCTGTGATGTGGATAATTTATTGATTGAATATTTTCAACCAGAGCCGCCTTTAGTATTAAAGTCTCATAGTGGTTCATGGCAGATATTGAGTAAAGGGAGTGGTTCGTACATTGTTTCTAGCCATGATGTTGAGTTAAATTATGAATTATGTGCAGTTAAATTTGGTACGGAAGATAAAGAAAAACAACGAGAGATAGTAAAAAATGCTATTTCAGAAAATAGTAAAAAAATGGTTTTTGCTTGCAAAGAGTGGTTAGACACTCGTATTTAG	MNYVESHSIICNAQIEDVYEIIINSDKWPGMFEPCQEVKTLFRDKEGEKIEIKALINGILMQWESNRKFYPETFSIKSKLNPPMTLVKEMETSWRVIKINSQQCVLLLEHLYDLESEVAGLIDGVETIEQAHQFISKAIDTNSVKELNNIKNIVESTEGSEKVLTGTITHSVVCEVPAQQVYTLVKDVSCWTGIFSFCDGAEVLKRSGNEELVEIKAKQNNKAVSWQTQRYYFDTIYRVDYVMPTPMPLLKTMNGRWQIIPINDQRCILTVQRNWGLLEDVSGIVDGIDNHDQANSFIISFINDNTRMEMDSIKSQVESHKKSNLLTFSAGYYIPHQVDDVYKIFLNIDDWSKILPHCDSVKVIYNDDKHQEFNMEVSTPNGNETFRSIRFCDVDNLLIEYFQPEPPLVLKSHSGSWQILSKGSGSYIVSSHDVELNYELCAVKFGTEDKEKQREIVKNAISENSKKMVFACKEWLDTRI	MQFKKISCLLLPPLFIFSSSIYAGNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGGYAKTKGTISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKEWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFINANLNPQKYPANIQRAINGTHQGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	125.33	gnl|BL_ORD_ID|3084|hsp_num:0	4266			99	324	
BGC0000196.1|Anthraquinone_3 # 3570 # 5117 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.348	BGC0000196.1|Anthraquinone_3 	3570	5117	-	Loose	1000	49.6766	almE	19.44	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAAACTAATCTCTATGTTGTTACATTCAGGGCGTGATAACTTACATCATGATTGTATTATCACTAAGGATTATCACTATACAAGAAAAGAGGTAATATCTTCTGTTTCCCATTTAATTGATGATTTACTTAGTCGAGGTGTTCAAAAAGGTAGTAAAGTCATTGTCATATTTGAACATGATGAATTAGGTATTTTCTTTTTAGCTGCGGCTAGTGCTATGGGGTTGCATTTATTAATGCCCTATAATTTATCATCAGCGACAATCGATGAATGGATTAATTTTACCAATGAAGTGCAATACGATTTTGTGGTTTACCTTAAGAAAGATAAACATTTTGTTGGAAGATTAAAAGAAAACAACATTAATGTGATTGATATTTCAGATCATAAGATCCGGGTCAGTGATGATATCGCGGAAATCCCAATAATAACTTATTCTCCGCAATCTATTGCTAACTTTATTGTCCTGTTCACCAGTGGTAGTACAGGTAAACCGAAAGCCATTAGTATTTCAGAATCATTAGTTTGTCGACGAATTTATTCGGTGACAGAGAAATTAAAATTCACTCAAGATGCTAAAATATTTATGTCAGGTTTGTTGAATAATACAACGGGAGTGATTTTTTCTTTCGGTTCATTATTACATCAATCAACACTTTTTATACCGGAAGACAGAAATGTAGAGAGATGGCCTGATTATCTTTCTCGTAATAAAATCACTCATATTATGTTACGCCCAGAGTCGATGAAGTTATTCGTTAAATCAACCGCAGAACATAATATCGATCTCTCTGACTTACAAGTTGTTGCTTATGGTGCCGCAGCGATGCCGCCTAGCGTACTGGAGAAAGGGCGTCAATTAATTGGCTGTGAATGGATGCAGGGATATGGGTTAAGTGAAACTTATGGTCCTTTTTGTTGGGTAGATGAGCAAGATCATCGTGATAAAAGATATCTCAATTCAATTTATTGTGTTGGCAAAATTGATAATACATTGGCGGTAGCGGTTAAACCTATTATAGGCTCATCTGATAATATTGGAGAAATTATAATAAGGGGTGAAAGTATTATGGAAGGATATTATGATGTCCTTTCTGGAGAAATAACACCTCCTGATGAGTGGTTTGCCACTGGTGATCTCGGTTATATAGATGAAGAGGGTTATTTAGTCTTAAAAGGACGTAAGCAAAATACTTTTATGAGTGCTAACGGACATAGAATTTATCCTGAAGAAGTTGAATCTATTTTATCCCGAATACCCAATGTGAATGTGGCTACGGTTGTTGGTTTTTCTTTCCATGAAAATGGTGTTGCTATTGATCAACCGGTTGCCTGCATGAGTGGCGAGATATCGAAGAAATCATTACCTGAAATTGAAGATATTATTTCATCATTTTTAAGTCGTAAACTCAGTAGAGAAAAATGGCCGGATTGGTTCTATGTTACTGATGAATACTTTCCAAAAAGCCATAATGATAAGATATTGAAAGCAGAGTTAATTAAGTCAATCGATCCTAAAAAACTATTTACATTGAGGAATCAATAA	MKLISMLLHSGRDNLHHDCIITKDYHYTRKEVISSVSHLIDDLLSRGVQKGSKVIVIFEHDELGIFFLAAASAMGLHLLMPYNLSSATIDEWINFTNEVQYDFVVYLKKDKHFVGRLKENNINVIDISDHKIRVSDDIAEIPIITYSPQSIANFIVLFTSGSTGKPKAISISESLVCRRIYSVTEKLKFTQDAKIFMSGLLNNTTGVIFSFGSLLHQSTLFIPEDRNVERWPDYLSRNKITHIMLRPESMKLFVKSTAEHNIDLSDLQVVAYGAAAMPPSVLEKGRQLIGCEWMQGYGLSETYGPFCWVDEQDHRDKRYLNSIYCVGKIDNTLAVAVKPIIGSSDNIGEIIIRGESIMEGYYDVLSGEITPPDEWFATGDLGYIDEEGYLVLKGRKQNTFMSANGHRIYPEEVESILSRIPNVNVATVVGFSFHENGVAIDQPVACMSGEISKKSLPEIEDIISSFLSRKLSREKWPDWFYVTDEYFPKSHNDKILKAELIKSIDPKKLFTLRNQ	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	92.63	gnl|BL_ORD_ID|4935|hsp_num:0	5928			105	1467	colistin A; colistin B
BGC0000196.1|Anthraquinone_4 # 5141 # 5389 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.333	BGC0000196.1|Anthraquinone_4 	5141	5389	-	Loose	400	26.5646	VIM-69	44.44	3005517	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGAATAATCATCCAGAAGTAAAAATAAAAACGATTTTGTCTCTTTTTCTTAACATTAATATTGATGATTTCAATATGGATGCAAACCTTGCTGATGCCTATGATATGGATTCTACGGAATTAGCTGACTTGGCAAAAGAGATTGAGAAAGAGTTCGGTATTTCCGTGACGAAAAGTCAATTCAGTCATTGGGAAACAGGAAGAGCAGTCCTTGATTTCGTCTCATCAAGTTTAAACGATAAAAATTAA	MNNHPEVKIKTILSLFLNINIDDFNMDANLADAYDMDSTELADLAKEIEKEFGISVTKSQFSHWETGRAVLDFVSSSLNDKN	MFQFRSFLVGISAFVMAVLGSAAYSAQPGGEYPTVDDIPVGEVRLYKIGDGVWSHIATQKLGDTVYSSNGLIVRDADELLLIDTAWGAKNTAALLAEIEKQIGLPVTRSISTHFHDDRVGGVDVLRAAGVATYASPLTRQLAEAAGNEVPTHSLKALSSSGDVVRFGPVEVFYPGAAHSGDNLVVYVPAVRVLFGGCAVHEASRESAGNVADANLAEWPATIKRIQQRYPEAEVVIPGHGLPGGLELLQHTTDVVKTHKVRPVAE	30.94	gnl|BL_ORD_ID|4647|hsp_num:0	5718			273	354	
BGC0000196.1|Anthraquinone_5 # 5424 # 6539 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.398	BGC0000196.1|Anthraquinone_5 	5424	6539	-	Loose	500	25.409	sul1	28.57	3000410	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGCGTAAAAGAGTTGTCGTTACCGGTGTTGGTGCAATACATCCTGATGGCAATGATGTCACTGCCATAAAATCAAAAGTCATTCAGAAGTTATTGGGACAAGAATCGAAAAACAATACCACCGCAAGTTCTATAATAAGGACATTGAGTGATTTCGATGGCGCGAAATATATCAATAACCGCTTAAGACGTAAAATTGATGAATTTTCGGTTTATGGTATCGTTGCCGTTGAAATGGCATTAAAAGCGAGTAGATTGGATGTCGATAAGCTTGATCCTAATCGCGTTGGCATATATGTCGGAAACTGTTTTGGTGGATGGCAACATATTGAGGATGAAGTTAAAGCGCTCCATATTGAAGGCATAAAGGGAATGGGGCCTTATGTTGCCACGGCATGGTTCCCTGCGGCACTTCAAGGGCAATTGTCACTGCTTTATGGTTTTAGTGCGCAATCTAAAACGTTTTCCACCTCCGATGTGGCAGGGATGCAAGCAATAGGCTATGCGGCGGAAGCAATTTCTAATGGTGTTGCGGAAGTGATGTTATGTGGTGCGTCAGAACATCTTTCCAGCCCATTAGTTAAAAATTTACTGGAGAAAACGTCAAGCCAGAAACACTCTGAGGTTTTTGGCGAAAAACAGCCAGGAGACTTTTCCGAAGGCGCGGCATTTCTGGTGCTGGAAGAGAGACAACATGCTTTAGAACGTGGTGCTTCGATATTGTGTGAATTAACCGGCTTTGTTGATTATTTTGCACCGGATAAAAATACTAGAAATAACACCTTAGAATATACCGCTGAACTGTTCAACCATAATGAAAATGCTGTATTTATTATGGATGGAATATATGATGATGAAAAAGAAATAACGAGTAAGGCTTTCTCAAATAAAGAGATAAAAACATCATTTATAAATCTGAGGCCCTATTTGGATAATCAATTTTCAGTCAGTGGCGTGATTGATTCAGTCCTGGCGTCATCATTCTTGTCAGAAAGTCATGGGGATGAGGAACAACAATCTAAAAAAATCAATGAGTTTTCAAATACTAACCAAATAATCATTCAGCGCTTTAGTAATCAAGGTCATGTGTGTGCGTTGAGTTTTTCAGCTATTTAA	MRKRVVVTGVGAIHPDGNDVTAIKSKVIQKLLGQESKNNTTASSIIRTLSDFDGAKYINNRLRRKIDEFSVYGIVAVEMALKASRLDVDKLDPNRVGIYVGNCFGGWQHIEDEVKALHIEGIKGMGPYVATAWFPAALQGQLSLLYGFSAQSKTFSTSDVAGMQAIGYAAEAISNGVAEVMLCGASEHLSSPLVKNLLEKTSSQKHSEVFGEKQPGDFSEGAAFLVLEERQHALERGASILCELTGFVDYFAPDKNTRNNTLEYTAELFNHNENAVFIMDGIYDDEKEITSKAFSNKEIKTSFINLRPYLDNQFSVSGVIDSVLASSFLSESHGDEEQQSKKINEFSNTNQIIIQRFSNQGHVCALSFSAI	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	132.97	gnl|BL_ORD_ID|979|hsp_num:0	1070			192	324	sulfadiazine; sulfadimidine; sulfadoxine; sulfamethoxazole; sulfisoxazole; sulfacetamide; mafenide; sulfasalazine; sulfamethizole
BGC0000196.1|Anthraquinone_8 # 9278 # 9994 # -1 # ID=1_8;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.304	BGC0000196.1|Anthraquinone_8 	9278	9994	-	Loose	600	30.0314	emtA	29.55	3004669	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; orthosomycin antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATCATGGACGATATTTCTTTATCATCTGATTTTTCTGATCTTTGGATTATAAAAATCGACGATATTGATTTATCTTCTATTGAACAGTTAATTCACCGGTCTGATATCGTTCGCCATAACCAAATTTGTTTAGCGGATAGAAGAAAAAAATTTATATTTAGACGGGCTGCGTTACGTTATGTTTTAAATCAATATTTATCTGATTATGAAATCATAACGAATGATAACGGTAAACCTTATATATCCACGGAGCAAGACTTCAAATATTATTTTTCTCTGAGTGCATCAGGAAACTATTGCGCCATCGGGTTTAGCTCAAGAGAAATAGGTGTTGATATTGAAGTCACTCCTTCTAAGATAAAATTTTCTGAAATTATTGAACGTTTTATTAAGGATAAGGAGTTGGAATATATAAAAGGTATAATGTTAAAACAACTATCAGGAGTGAGTCCCGGATTTAAAAACTATTATCACTTAATGTCATTATACTGTTGGGTTAGACTTGAAGCATATATTAAATTATTTGCTTCGACTTTACATGAGAAATTATTGGCTAATAACTCTGATTCTGTTAAAGATATGAAAGAATTAGAGGCGAGCACATTATTGATTCATCATCAGCAATTTGTTTGTGCATTATCTCAAAAGAAGGTAATTTCTACACCAAATATCAAGGAAATAAACTATTTCGAGATTATAAGGAACAAAGATGAGTAA	IMDDISLSSDFSDLWIIKIDDIDLSSIEQLIHRSDIVRHNQICLADRRKKFIFRRAALRYVLNQYLSDYEIITNDNGKPYISTEQDFKYYFSLSASGNYCAIGFSSREIGVDIEVTPSKIKFSEIIERFIKDKELEYIKGIMLKQLSGVSPGFKNYYHLMSLYCWVRLEAYIKLFASTLHEKLLANNSDSVKDMKELEASTLLIHHQQFVCALSQKKVISTPNIKEINYFEIIRNKDE	MTLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVIDQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINKRYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMVWLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVWDARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVNQLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDGLRRK	69.79	gnl|BL_ORD_ID|2212|hsp_num:0	3368			27	264	evernimicin
